Saltar al contenido
MilliporeSigma
Todas las fotos(2)

Documentos clave

RV1MAG-26K

Millipore

MILLIPLEX® Rat Vascular Injury Magnetic Bead Panel 1 - Toxicity Multiplex Assay

The analytes available for this multiplex kit are: Caveolin-1, CINC-1/GRO/KC, CTGF (Connective Tissue Growth Factor), IL-6, MCP-1, PAI-1 (total), TIMP-1, TNFα, VEGF.

Sinónimos:

Luminex® Rat Vascular Injury Panel, Millipore Rat Vascualr Injury Panel, Rat Vascular Injury Multiplex Assay

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(2)

About This Item

Código UNSPSC:
12161503
eCl@ss:
32161000
NACRES:
NA.84
To order a Milliplex® kit, please search for your analyte of interest.
Design And Price Your Kit

Nivel de calidad

200

reactividad de especies

rat

fabricante / nombre comercial

Milliplex®

assay range

accuracy: 97-108%
intra-assay cv: <10%
standard curve range: 0.1-100 ng/mL
(CINC-1/GRO/KC, IL-6, MCP-1, PAI-1 (total))
standard curve range: 0.1-15 ng/mL
(VEGF)
standard curve range: 0.1-20 ng/mL
(TNFα)
standard curve range: 0.2-150 ng/mL
(TIMP-1)
standard curve range: 0.3-200 ng/mL
(CTGF)
standard curve range: 1.4-1,000 ng/mL
(Caveolin-1)
inter-assay cv: <10%
(All other analytes)
inter-assay cv: <15%
(CINC-1/GRO/KC, PAI-1 (total), TIMP-1, TNFα)
inter-assay cv: <20%
(Caveolin-1)

técnicas

multiplexing: suitable

método de detección

fluorometric (Luminex xMAP)

Condiciones de envío

wet ice

Descripción general

Vascular injury is important to address during the preclinical safety study of drugs. A lack of well-defined mechanisms of drug-induced vascular injury (DIVI) in animals, and the absence of specific, qualified biomarkers have become significant barriers in the development of new therapeutic treatments. In the past, hemodynamics, such as heart rate and mean arterial blood pressure, were used to measure DIVI risks but these only targeted single biomarkers. Today, some of the known vascular injury mechanisms are related to vascular wall shear and/or circumferential “hoop” stress, drug/chemical toxicity, and immunological mediation. With these known biomechanics, primary targets (smooth muscle, endothelial and immune-mediated cells) yield a number of promising candidate biomarkers for DIVI study. We provide valuable research assays to investigate multiple biomarkers of vascular injury in rat serum and plasma samples using the Luminex® xMAP® instrument platform.

The MILLIPLEX® Rat Vascular Injury Bead Panel contains all the components necessary to measure the following 9 biomarkers in any combination using Luminex® xMAP® technology: Caveolin-1, CINC-1/GRO/KC, CTGF (Connective Tissue Growth Factor), IL-6, MCP-1, PAI-1 (total), TIMP-1, TNFα, VEGF. The kit uses a 96-well format, contains a lyophilized standard cocktail, 2 quality controls and can measure up to 38 serum or plasma samples in duplicate.

Panel Type: Toxicity

Especificidad

There was no or negligible cross-reactivity between the antibodies for an analyte and any of the other analytes within a panel.

Aplicación

  • Analytes: Caveolin-1, CINC-1/GRO/KC, CTGF (Connective Tissue Growth Factor), IL-6, MCP-1, PAI-1 (total), TIMP-1, TNF-α, VEGF
  • Recommended Sample type: serum and plasma
  • Recommended Sample dilution: 1:4 in kit Serum Matrix
  • Assay Run Time: Overnight
  • Research Category: Toxicity

Características y beneficios

Design your multiplex kit by choosing available analytes within this panel.

Envase

Everything you need in a single kit.

Almacenamiento y estabilidad

Recommended storage for kit components is 2 - 8°C.

Otras notas

Please contact Technical Service for linearity of dilution.
Sensitivity: See kit protocol for individual analytes sensitivities.

Información legal

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Cláusula de descargo de responsabilidad

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Palabra de señalización

Danger

Clasificaciones de peligro

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

Órganos de actuación

Respiratory Tract

Código de clase de almacenamiento

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Philipp Baumann et al.
American journal of translational research, 14(1), 343-354 (2022-02-18)
Intensive care practice calls for ventilator adjustments due to fast-changing clinical conditions in ventilated critically ill children. These adaptations include positive end-expiratory pressure (PEEP), fraction of inspired oxygen (FiO2), and respiratory rate (RR). It is unclear which alterations in ventilator
Evandro M Neto-Neves et al.
The American journal of pathology, 187(4), 700-712 (2017-02-12)
Our understanding of the pathophysiological basis of chronic thromboembolic pulmonary hypertension (CTEPH) will be accelerated by an animal model that replicates the phenotype of human CTEPH. Sprague-Dawley rats were administered a combination of a single dose each of plastic microspheres
Philipp Baumann et al.
Physiological reports, 6(2) (2018-01-31)
Mechanical ventilation (MV) is routinely used in pediatric general anesthesia and critical care, but may adversely affect the cardiocirculatory system. Biomarkers are increasingly measured to assess cardiovascular status and improve clinical treatment decision-making. As the impact of mechanical ventilation strategies
Mary F Barbe et al.
Journal of musculoskeletal & neuronal interactions, 19(4), 396-411 (2019-12-04)
Fibrosis is one contributing factor in motor dysfunction and discomfort in patients with overuse musculoskeletal disorders. We pharmacologically targeted the primary receptor for Substance P, neurokinin-1, using a specific antagonist (NK1RA) in a rat model of overuse with the goal
Fabrice Antigny et al.
Circulation, 133(14), 1371-1385 (2016-02-26)
Mutations in the KCNK3 gene have been identified in some patients suffering from heritable pulmonary arterial hypertension (PAH). KCNK3 encodes an outward rectifier K(+) channel, and each identified mutation leads to a loss of function. However, the pathophysiological role of

Contenido relacionado

Multiplex Toxicity Assays | MILLIPLEX® Assays

Multiplex toxicity assays enable researchers to simultaneously measure multiple toxicity biomarkers of various organs to gain a better understanding of toxicity. Explore how MILLIPLEX® multiplex toxicity assays are advancing research on liver injury, kidney toxicity, genotoxicity, and more.

Questions

Reviews

No rating value

Active Filters

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico